A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis

EBioMedicine

Volumn 16, Issue , 2017, Pages 136-140

  Wong, Susan J ^a   Furuya, Andrea ^a   Zou, Jing ^b   Xie, Xuping ^b   Dupuis, Alan P ^a   Kramer, Laura D ^a   Shi, Pei Yong ^b,c  

^a WADSWORTH CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Diagnosis; Multiplex microsphere immunoassay; Serologic assay; Zika virus

Indexed keywords

ENVELOPE PROTEIN; IMMUNOGLOBULIN M ANTIBODY; MICROSPHERE; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 5; RECOMBINANT PROTEIN; VIRAL PROTEIN; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DENGUE VIRUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; MULTIPLEX MICROSPHERE IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERODIAGNOSIS; TURNAROUND TIME; VIRAL DISEASE IMMUNOFLUORESCENCE ASSAY; VIRUS NEUTRALIZATION; VIRUS PLAQUE; ZIKA FEVER; ANIMAL; BLOOD; CHLOROCEBUS AETHIOPS; DENGUE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VERO CELL LINE; VIROLOGY; ZIKA VIRUS; ZIKA VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; CROSS REACTIONS; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOASSAY; MICROSPHERES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85009817234     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2017.01.008     Document Type: Article

References (15)

1. Calvet, G.A., Santos, F.B., Sequeira, P.C., Zika virus infection: epidemiology, clinical manifestations and diagnosis. Curr. Opin. Infect. Dis. 29 (2016), 459–466.
2. Garcia, G., Vaughn, D.W., Del Angel, R.M., Recognition of synthetic oligopeptides from nonstructural proteins NS1 and NS3 of dengue-4 virus by sera from dengue virus-infected children. Am.J.Trop. Med. Hyg. 56 (1997), 466–470.
3. Lanciotti, R.S., Kosoy, O.L., Laven, J.J., Velez, J.O., Lambert, A.J., Johnson, A.J., Stanfield, S.M., Duffy, M.R., Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14 (2008), 1232–1239.
4. Lindenbach, B.D., Murray, C.L., Thiel, H.J., Rice, C.M., Flaviviridae. Knipe, D.M., Howley, P.M., (eds.) Fields Virology, 6th, vol. 1, 2013, Lippincott William & Wilkins, Philadelphia, 712–746.
5. Martin, D.A., Muth, D.A., Brown, T., Johnson, A.J., Karabatsos, N., Roehrig, J.T., Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J. Clin. Microbiol. 38 (2000), 1823–1826.
6. Musso, D., Gubler, D.J., Zika virus. Clin. Microbiol. Rev. 29 (2016), 487–524.
7. Russell, K., Oliver, S.E., Lewis, L., Barfield, W.D., Cragan, J., Meaney-Delman, D., Staples, J.E., Fischer, M., Peacock, G., Oduyebo, T., et al. Update: interim guidance for the evaluation and management of infants with possible congenital Zika virus infection - United States, August 2016. MMWR Morb. Mortal. Wkly Rep. 65 (2016), 870–878.
8. Shan, C., Xie, X., Barrett, A.D.T., Garcia-Blanco, M.A., Tesh, R.B., Vasconcelos, P.F.D.C., Vasilakis, N., Weaver, S.C., Shi, P.Y., Zika virus: diagnosis, therapeutics, and vaccine. ACS Infect. Dis. 2 (2016), 170–172.
9. Shan, C., Xie, X., Muruato, A.E., Rossi, S.L., Roundy, C.M., Azar, S.R., Yang, Y., Tesh, R.B., Bourne, N., Barrett, A.D., et al. An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors. Cell Host Microbe 19 (2016), 891–900.
10. Shu, P.Y., Chen, L.K., Chang, S.F., Yueh, Y.Y., Chow, L., Chien, L.J., Chin, C., Yang, H.H., Lin, T.H., Huang, J.H., Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: correlation of results with those of the plaque reduction neutralization test. J. Clin. Microbiol. 40 (2002), 1840–1844.
11. Stettler, K., Beltramello, M., Espinosa, D.A., Graham, V., Cassotta, A., Bianchi, S., Vanzetta, F., Minola, A., Jaconi, S., Mele, F., et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353 (2016), 823–826.
12. Weaver, S.C., Costa, F., Garcia-Blanco, M.A., Ko, A.I., Ribeiro, G.S., Saade, G., Shi, P.Y., Vasilakis, N., Zika virus: history, emergence, biology, and prospects for control. Antivir. Res. 130 (2016), 69–80.
13. Wong, S.J., Boyle, R.H., Demarest, V.L., Woodmansee, A.N., Kramer, L.D., Li, H., Drebot, M., Koski, R.A., Fikrig, E., Martin, D.A., et al. An immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections, and form flavivirus vaccination. J. Clin. Microbiol. 41 (2003), 4217–4223.
14. Zhao, Y., Soh, T.S., Chan, K.W., Fung, S.S., Swaminathan, K., Lim, S.P., Shi, P.Y., Huber, T., Lescar, J., Luo, D., et al. Flexibility of NS5 methyltransferase-polymerase linker region is essential for dengue virus replication. J. Virol. 89 (2015), 10717–10721.
15. Zhao, H., Fernandez, E., Dowd, K.A., Speer, S.D., Platt, D.J., Gorman, M.J., Govero, J., Nelson, C.A., Pierson, T.C., Diamond, M.S., et al. Structural basis of Zika virus-specific antibody protection. Cell 166 (2016), 1016–1027.